×
App Icon
The Standard e-Paper
Smart Minds Choose Us
★★★★ - on Play Store
Download App

Medical interventions to manage dwarfism, boost victims development

A global trial is currently ongoing to develop a drug that will regulate the development of bones for children with dwarfism.

The clinical trial is coming up with a drug composition that will boost the growth rates of children with achondroplasia, the most common form of dwarfism.

Get Full Access for Ksh299/Week.
Bold Reporting Takes Time, Courage and Investment. Stand With Us.
  • Unlimited access to all premium content
  • Uninterrupted ad-free browsing experience
  • Mobile-optimized reading experience
  • Weekly Newsletters
  • MPesa, Airtel Money and Cards accepted
Already a subscriber? Log in

Related Topics

Dwarfism Health